ELEVATION ONCOLOGY INC (ELEV)

ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024

ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024.

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

7 Top Stocks Under $7

Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now.

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

5 Healthcare Stocks to Buy for 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

5 Healthcare Stocks to Buy for 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips What has been the top-performing stock so far of 2024? If you had said serve...

ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023

ELEV stock results show that Elevation Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.

ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Elevation Oncology (NASDAQ:ELEV) just reported results for the fourth quarter o...

Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements

--Expanded ongoing Phase 1 clinical trial of EO-3021 globally, dosing first patient in Japan; on track to provide update in mid-2024 and to report additional...

Trim the Fat: 3 Overbought Stocks Poised for a Pullback

While these companies have seen a stratospheric rise in their market value, they’re now candidates for overbought stocks to sell.

Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

3 Stock Winners That Are Up 400% or More in 2024

Explore stocks winners of 2024, including MicroCloud, Beamr Imaging, and Elevation Oncology, each seeing 400% gains in a GenAI-led rally.

Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Elevation Oncology gets new CEO and promotes to CFO (NASDAQ:ELEV)

Innovative oncology company Elevation Oncology (ELEV), appoints Joseph Ferra as its CEO.  Mr. Ferra was previously interim CEO and CFO. Mr

Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...